SANUWAVE Health (SNWV) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn | 2.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.47% |
| Dec 31, 2025 | 218.22% |
| Sep 30, 2025 | 9,422.92% |
| Jun 30, 2025 | -1,159.78% |
| Mar 31, 2025 | -42.11% |
| Dec 31, 2024 | -233.33% |
| Sep 30, 2024 | -469.23% |
| Jun 30, 2024 | 39.07% |
| Mar 31, 2024 | -533.33% |
| Dec 31, 2023 | 125.65% |
| Sep 30, 2023 | -82.43% |
| Jun 30, 2023 | -125.68% |
| Mar 31, 2023 | -105.00% |
| Dec 31, 2022 | -684.09% |
| Sep 30, 2022 | 145.12% |
| Jun 30, 2022 | 434.09% |
| Mar 31, 2022 | 456.44% |
| Dec 31, 2021 | -528.57% |
| Sep 30, 2021 | 99.13% |
| Jun 30, 2021 | 84.14% |
| Mar 31, 2021 | -1,920.00% |
| Dec 31, 2020 | 43.89% |
| Sep 30, 2020 | -600,471.25% |
| Jun 30, 2020 | -29,226.29% |
| Mar 31, 2020 | 77.33% |
| Dec 31, 2019 | -132.80% |
| Sep 30, 2019 | 83.02% |
| Jun 30, 2019 | 35.76% |
| Mar 31, 2019 | -185.67% |
| Mar 31, 2014 | -125.93% |
| Mar 31, 2013 | 893.65% |
| Sep 30, 2012 | 93.01% |
| Sep 30, 2011 | -438.71% |